anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Daré Bioscience · pitchdeck

Dare Bioscience | Investor Presentation Deck | 50 slides

50 pages · 5 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Dare Bioscience | Investor Presentation Deck | 50 slides

Daré Bioscience · 2022-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 9 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Solution 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Product 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Financials 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

50
every slide · same image gating as the playbook
01
Slide 1
The slide uses a play on words between Italian and English to define the brand identity.front_matter
Open slide detail
02
other
Open slide detail
03
inspire_vision
Open slide detailLoop · Golden Circle
04
Uses a contrast-based argument: low research investment vs. high market performance.size_opportunity
Open slide detailLoop · Golden Circle
05
Uses a comparative framework to validate market potential by citing peak sales of existing products.size_opportunity
Open slide detailBeat · Market Size
06
The slide uses a 2x2 grid layout to organize the portfolio by therapeutic area.summarize
Open slide detail
07
The slide uses a numbered list to outline the investment thesis and a callout box for specific 2022 milestones.summarize
Open slide detail
08
The slide uses a horizontal bar chart format to represent clinical trial stages for various assets.plan_implementation
Open slide detail
09
Includes regulatory status and financial terms of the licensing deal.show_traction
Open slide detail
10
Slide highlights clinical development status and key value propositions for two lead assets.present_solution
Open slide detail
11
The slide uses a structured grid layout to present seven distinct product development programs.plan_implementation
Open slide detail
12
The slide uses a flow-like diagram to connect internal strengths to external market trends, supported by a list of recent industry transactions.argue_timing
Open slide detail
13
The slide uses a two-column layout for team members and a logo grid at the bottom to establish credibility.other
Open slide detail
14
show_traction
Open slide detailBeat · Financials
15
The slide uses a callout box to summarize the upcoming milestones for the company's pipeline.plan_implementation
Open slide detail
16
Includes regulatory status and commercial partnership details.present_solution
Open slide detailBeat · Product
17
The slide uses a three-row layout to contrast the problem, current limitations, and the proposed solution.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
18
Slide 18 of the deck.establish_context
Open slide detailLoop · Cost Of Inaction
19
The slide highlights a key business development milestone involving a $10M upfront payment and potential $182.5M in milestones.show_traction
Open slide detail
20
Standard pharmaceutical ISI (Important Safety Information) slide.other
Open slide detail
21
This slide provides regulatory/clinical disclosure information regarding special populations.other
Open slide detail
22
The slide uses a high-contrast design with a large yellow circle on a blue background to emphasize the product name.establish_context
Open slide detail
23
The slide uses a combination of a demographic projection chart and a hub-and-spoke diagram of successful products to establish market scale.size_opportunity
Open slide detail
24
Uses a tree-like decomposition to show the total addressable market and its sub-segments.size_opportunity
Open slide detail
25
The slide uses a vertical effectiveness scale to position existing methods and highlight the 'missing' product category.frame_problem
Open slide detail
26
The slide uses a comparison framework to map user needs to product capabilities.present_solution
Open slide detailBeat · Solution
27
Highlights the validation of the product by a major industry player (Bayer) and the financial terms of the deal.show_traction
Open slide detail
28
Includes a testimonial/quote from a partner at the bottom.show_traction
Open slide detail
29
Includes specific clinical data points from a Postcoital Test (PCT) study.analyze_data
Open slide detail
30
The slide highlights the lack of existing FDA-approved therapies for FSAD.present_solution
Open slide detail
31
Uses a visual inequality symbol to emphasize the distinction between FSAD and HSDD.frame_problem
Open slide detail
32
The slide uses a two-part structure: global meta-analysis data followed by US-specific market sizing.size_opportunity
Open slide detail
33
The slide uses a bulleted list to define the product profile and concludes with a strong market gap statement regarding FSAD.present_solution
Open slide detail
34
The slide outlines the methodology and status of a clinical trial.show_traction
Open slide detail
35
The slide uses clinical trial data to justify the pivot to a topical delivery mechanism.show_traction
Open slide detail
36
Includes both tabular pharmacokinetic data and a line chart showing plasma concentration over time.show_traction
Open slide detail
37
Study design is a small N=6 crossover trial.analyze_data
Open slide detail
38
transition
Open slide detail
39
The slide uses a grid layout to organize seven distinct product candidates with their respective development status and value propositions.plan_implementation
Open slide detail
40
The slide uses a side-by-side comparison structure to link the biological rationale with the technical solution.present_solution
Open slide detail
41
The slide highlights the lack of FDA-approved monthly IVR options for combined hormone therapy.present_solution
Open slide detail
42
The slide details results from two completed studies (Phase 1 and Phase 1/2) for a hormone therapy product.show_traction
Open slide detail
43
The slide highlights the clinical need for a long-acting progesterone delivery system for preterm birth prevention and IVF support.present_solution
Open slide detail
44
The slide highlights the regulatory pathway (505(b)(2)) and the specific patient population (HR+ breast cancer survivors).present_solution
Open slide detail
45
The slide presents clinical trial data comparing baseline to month 3 outcomes and systemic absorption levels.show_traction
Open slide detail
46
The slide details the methodology of a clinical trial, including randomization, dosing groups, and primary/secondary endpoints.present_framework
Open slide detail
47
The slide uses a comparative structure to frame the problem (limitations of current standard) and the solution (target product profile).frame_problem
Open slide detail
48
The slide outlines a development roadmap with specific milestones and associated funding amounts.plan_implementation
Open slide detail
49
The slide uses a callout box to highlight the mechanism of action and clinical potential of GML.present_solution
Open slide detail
50
The slide uses a triptych of images to visually represent the company's 'Dare to be Bold' ethos.inspire_vision
Open slide detail